You have 9 free searches left this month | for more free features.

Chemohormonal therapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Trial in Madison (Docetaxel, Degarelix, Bicalutamide)

Completed
  • Prostate Cancer
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Sep 12, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Portland, Seattle

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Portland, Oregon
  • +2 more
Jun 24, 2022

Prostate Cancer Trial in Washington, Baltimore (drug, procedure, radiation)

Completed
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +2 more
Jul 11, 2022

Prostate Cancer Trial in Washington, Baltimore (Leuprolide Acetate, Docetaxel, Bicalutamide)

Active, not recruiting
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +1 more
Mar 29, 2022

Metastatic Hormone-sensitive Prostate Cancer Trial in United States (androgen-deprivation therapy, docetaxel)

Active, not recruiting
  • Metastatic Hormone-sensitive Prostate Cancer
  • Anchorage, Alaska
  • +342 more
Jan 29, 2023

Prostate Cancer, Oligometastasis, Oligorecurrence Trial in United States (procedure, radiation, other, drug)

Recruiting
  • Prostate Cancer
  • +4 more
  • PET-directed Local Therapy using Surgery
  • +10 more
  • Long Beach, California
  • +15 more
Jul 29, 2022

Prostate Cancer Trial in Hamburg (Radical prostatectomy, Best systemic therapy)

Active, not recruiting
  • Prostate Cancer
  • Radical prostatectomy
  • Best systemic therapy
  • Hamburg, Nein, Germany
    Markus Graefen
May 6, 2022

Prostate Cancer, Stage IV Prostate Cancer Trial in Tampa (Luteinizing Hormone Releasing Hormone, New Hormonal Agent, Docetaxel)

Recruiting
  • Prostate Cancer
  • Stage IV Prostate Cancer
  • Luteinizing Hormone Releasing Hormone
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jun 1, 2022

Solid Tumor Trial in United States (CPO-100)

Recruiting
  • Solid Tumor
  • Los Angeles, California
  • +9 more
Dec 16, 2022

Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial (INKmune)

Not yet recruiting
  • Cancer
  • +2 more
  • INKmune
  • (no location specified)
Sep 27, 2023

Predictive fActors for toleraNce to Taxane Based CHemotherapy In

Completed
  • Elderly Patients
  • Metastatic Prostate Cancer
  • Taxane chemotherapy
  • Florence, Italy
    AOU Careggi Radiation Oncology Unit
Jul 21, 2022

Rectal Cancer Trial in Guangzhou (watch and wait)

Recruiting
  • Rectal Cancer
  • watch and wait
  • Guangzhou, Guangdong, China
    Sun Yatsen University
May 10, 2021

Colorectal Cancer, Immunotherapy Trial in Guangzhou (mFOLFOX6+Bevacizumab+PD-1 mAb treatment combinations)

Recruiting
  • Colorectal Cancer
  • Immunotherapy
  • mFOLFOX6+Bevacizumab+PD-1 monoclonal antibody treatment combinations
  • Guangzhou, Guangdong, China
    Sun Yatsen University
May 19, 2021

Prostate Cancer Trial in Shatin (Apalutamide, Enzalutamide)

Recruiting
  • Prostate Cancer
  • Shatin, Hong Kong
    Prince of Wales Hospital
Aug 3, 2021

Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7 Trial in Worldwide (drug, other, radiation)

Active, not recruiting
  • Breast Adenocarcinoma
  • +6 more
  • Anniston, Alabama
  • +1230 more
Jan 28, 2023

Prostate Cancer, Chemo Effect, Hormone Sensitive Prostate Cancer Trial (Neoadjuvant chemo combined with hormone therapy,

Not yet recruiting
  • Prostate Cancer
  • +3 more
  • Neoadjuvant chemotherapy combined with hormone therapy
  • +2 more
  • (no location specified)
Jan 4, 2020

Prostate Adenocarcinoma Trial in San Francisco (behavioral, other, drug)

Terminated
  • Prostate Adenocarcinoma
  • Behavioral Dietary Intervention
  • +8 more
  • San Francisco, California
    University of California, San Francisco
Jul 21, 2020

Obstructive Sleep Apnea, Sleep Apnea Trial (Proactive Therapy)

Not yet recruiting
  • Obstructive Sleep Apnea
  • Sleep Apnea
  • Proactive Therapy
  • (no location specified)
Nov 17, 2023

Spinal Cord Injuries, Walking, Difficulty Trial in Ankara (Exoskeletal robotic therapy for walking., Conventional exercise

Completed
  • Spinal Cord Injuries
  • Walking, Difficulty
  • Exoskeletal robotic therapy for walking.
  • Conventional exercise therapy
  • Ankara, Turkey
    Ankara City Hospital
Nov 14, 2023

Oligozoospermia, Oligoasthenozoospermia, Oligoasthenoteratozoospermia Trial in Jakarta (Electroacupuncture and Standard Therapy)

Recruiting
  • Oligozoospermia
  • +2 more
  • Electroacupuncture and Standard Therapy
  • Jakarta, Jakarta Timur, Indonesia
    Lisa Yunita
Oct 12, 2023

IBD, IBD, Crohn Disease Trial in Tel Aviv (photobiomodulation treatment in the infrared (IR) range.)

Recruiting
  • IBD
  • +2 more
  • photobiomodulation treatment in the infrared (IR) range.
  • Tel Aviv, Israel
    Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center
Nov 19, 2023

Brain Metastases Trial (Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Stereotactic Radiation Therapy)

Not yet recruiting
  • Brain Metastases
  • Gamma Tile-Surgically Targeted Radiation Therapy (STaRT)
  • Stereotactic Radiation Therapy
  • (no location specified)
Jun 2, 2023

Auditory Hallucination, Psychotic Disorders, Schizophrenia and Related Disorders Trial in Hawthorn (Avatar therapy, Cognitive

Recruiting
  • Auditory Hallucination
  • +2 more
  • Avatar therapy
  • Cognitive behavioural therapy (CBT)
  • Hawthorn, Victoria, Australia
    Swinburne University of Technology
Aug 4, 2023

Multiple Sclerosis Trial in Boston (drug, behavioral, other)

Not yet recruiting
  • Multiple Sclerosis
  • Dalfampridine 10 MG [Ampyra]
  • +2 more
  • Boston, Massachusetts
    MGH Institute of Health Professions
Nov 13, 2023

Lymphoma Trial in Seattle (biological, other, procedure)

Not yet recruiting
  • Lymphoma
  • Immune Globulin Infusion (Human), 10% Solution
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 21, 2023